Akero Therapeutics (AKRO) PT Lowered to $39 at UBS
Tweet
Share
E-mailGet Alerts AKRO Hot Sheet
Price: $54.74 --0%
Rating Summary:
12 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 14
Rating Summary:
12 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 14
Join SI Premium – FREE
UBS analyst Eliana Merle lowered the price target on Akero Therapeutics (NASDAQ: AKRO) to $39.00 (from $83.00) while maintaining a Buy rating.
You May Also Be Interested In
- Nomura/Instinet Downgrades China Literature (772:HK) (CHLLF) to Neutral
- Money Forward Inc (3994:JP) PT Raised to JPY5,500 at Nomura/Instinet
- HA Sustainable Infrastructure Ca (HASI) PT Lowered to $45 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
